Biodexa Pharmaceuticals Plc (BDRX)
0.8733
+0.26
(+42.23%)
USD |
NASDAQ |
Apr 02, 16:00
0.843
-0.03
(-3.47%)
Pre-Market: 20:00
Biodexa Pharmaceuticals Enterprise Value
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| NuCana Plc | -24.93M |
| Mereo BioPharma Group Plc | 10.09M |
| Bicycle Therapeutics Plc | -259.12M |
| Autolus Therapeutics Plc | 424.64M |
| GSK Plc | 131.98B |
Enterprise Value Related Metrics
| Earnings Yield | -2.38K% |
| Normalized Earnings Yield | -2372.79 |